**Author details**

Mammari Nour\* and Halabi Mohamad Adnan Holy Family University, Batroun, Lebanon

\*Address all correspondence to: nour.maamari@usf.edu.lb; nor-mammari@hotmail.fr

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**127**

2015;**22**:39

Toxoplasma *Immunomodulation Related to Neuropsychiatric Diseases*

[10] Ajzenberg D. Type I strains in human toxoplasmosis: Myth or reality? Future Microbiology.

[11] Delhaes L, Ajzenberg D, Sicot B, et al. Severe congenital toxoplasmosis due to a *Toxoplasma gondii* strain with an atypical genotype: Case report and review. Prenatal Diagnosis.

[12] Konradt C, Ueno N, Christian DA, et al. Endothelial cells are a replicative niche for entry of *Toxoplasma gondii* to the central nervous system. Nature

[13] Mammari N, Vignoles P, Halabi MA,

Microbiology. 2016;**1**:16001

et al. In vitro infection of human nervous cells by two strains of *Toxoplasma gondii*: A kinetic analysis of immune mediators and parasite multiplication. PLoS ONE.

[14] Corcino YL, Portillo J-AC,

Scientific Reports. 2019;**9**:669

[16] Goverman J. Autoimmune T cell responses in the central nervous system. Nature Reviews. Immunology.

[17] Tosh KW, Mittereder L, Bonne-Annee S, et al. The IL-12 response of primary human DC and monocytes to *Toxoplasma gondii* is stimulated by phagocytosis of live parasites rather than host cell invasion. Journal of Immunology (Baltimore, Md. : 1950).

Subauste CS. Epidermal growth factor receptor promotes cerebral and retinal invasion by *Toxoplasma gondii*.

[15] Schlüter D, Barragan A. Advances and challenges in understanding cerebral toxoplasmosis. Frontiers in Immunology. 14 February 2019;**10**. DOI: 10.3389/fimmu.2019.00242. [Epub

2010;**5**:841-843

2010;**30**:902-905

2014;**9**:e98491

ahead of print]

2009;**9**:393

2016;**196**:345-356

*DOI: http://dx.doi.org/10.5772/intechopen.86695*

[1] Dalimi A, Abdoli A. Latent toxoplasmosis and human. Iranian Journal of Parasitology. 2012;**7**:1-17

[2] Buoli M, Serati M, Caldiroli A, et al. Neurodevelopmental versus neurodegenerative model of schizophrenia and bipolar disorder: Comparison with physiological brain development and aging. Psychiatria

[3] Syn G, Anderson D, Blackwell JM, et al. Epigenetic dysregulation of host gene expression in *Toxoplasma* infection with specific reference to dopamine and amyloid pathways. Infection, Genetics

and Evolution. 2018;**65**:159-162

2018;**13**:317-322

2018;**152**:117-122

2014;**60**:83-88

[6] Halonen SK, Weiss LM.

Neurology. 2013;**114**:125-145

[4] Soleymani E, Babamahmoodi F, Davoodi L, et al. Toxoplasmic encephalitis in an AIDS patient with normal CD4 count: A case report. Iranian Journal of Parasitology.

[5] Marra CM. Central nervous system infection with *Toxoplasma gondii*. Handbook of Clinical Neurology.

Toxoplasmosis. Handbook of Clinical

[7] Długońska H. *Toxoplasma gondii* and the host cells. Annals of Parasitology.

[8] Hunter CA, Sibley LD. Modulation of innate immunity by *Toxoplasma gondii* virulence effectors. Nature Reviews. Microbiology. 2012;**10**:766-778

[9] Mammari N, Vignoles P, Halabi MA, et al. Interferon gamma effect on immune mediator production in human nerve cells infected by two strains of *Toxoplasma gondii*. Parasite: Journal de la Société Française de Parasitologie.

Danubina. 2017;**29**:24-27

**References**

Toxoplasma *Immunomodulation Related to Neuropsychiatric Diseases DOI: http://dx.doi.org/10.5772/intechopen.86695*
